Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
Condition(s):Covid19; Pneumonia, ViralLast Updated:December 21, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Covid19; Pneumonia, ViralLast Updated:December 21, 2020Withdrawn
Condition(s):Bronchiectasis AdultLast Updated:April 14, 2023Recruiting
Condition(s):Emphysema; Alpha 1-Antitrypsin DeficiencyLast Updated:April 21, 2020Completed
Condition(s):Alpha-1-antitrypsin DeficiencyLast Updated:January 5, 2022Recruiting
Condition(s):Alpha 1-Antitrypsin DeficiencyLast Updated:June 24, 2005Terminated
Condition(s):Alpha-1 Antitrypsin DeficiencyLast Updated:March 31, 2022Completed
Condition(s):Alpha 1-Antitrypsin Deficiency; EmphysemaLast Updated:March 5, 2024Not yet recruiting
Condition(s):Lung Diseases; Emphysema; Alpha-1 Antitrypsin Deficiency; Chronic Obstructive Pulmonary DiseaseLast Updated:March 25, 2016Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:November 30, 2022Recruiting
Condition(s):SarcoidosisLast Updated:January 12, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.